rs199714523

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6BS2_Supporting

The NM_024301.5(FKRP):ā€‹c.456C>Gā€‹(p.Ser152Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000884 in 1,523,414 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00067 ( 1 hom., cov: 33)
Exomes š‘“: 0.00091 ( 2 hom. )

Consequence

FKRP
NM_024301.5 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:11B:2

Conservation

PhyloP100: -1.72
Variant links:
Genes affected
FKRP (HGNC:17997): (fukutin related protein) This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012802839).
BP6
Variant 19-46755906-C-G is Benign according to our data. Variant chr19-46755906-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 289565.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=9}. Variant chr19-46755906-C-G is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FKRPNM_024301.5 linkuse as main transcriptc.456C>G p.Ser152Arg missense_variant 4/4 ENST00000318584.10 NP_077277.1 Q9H9S5A0A024R0R7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FKRPENST00000318584.10 linkuse as main transcriptc.456C>G p.Ser152Arg missense_variant 4/41 NM_024301.5 ENSP00000326570.4 Q9H9S5

Frequencies

GnomAD3 genomes
AF:
0.000670
AC:
102
AN:
152224
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00132
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000500
AC:
60
AN:
119918
Hom.:
0
AF XY:
0.000409
AC XY:
27
AN XY:
65968
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000174
Gnomad NFE exome
AF:
0.00132
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000908
AC:
1245
AN:
1371190
Hom.:
2
Cov.:
32
AF XY:
0.000889
AC XY:
601
AN XY:
676034
show subpopulations
Gnomad4 AFR exome
AF:
0.0000651
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000294
Gnomad4 NFE exome
AF:
0.00113
Gnomad4 OTH exome
AF:
0.000297
GnomAD4 genome
AF:
0.000670
AC:
102
AN:
152224
Hom.:
1
Cov.:
33
AF XY:
0.000646
AC XY:
48
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.000289
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00132
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000287
Hom.:
0
Bravo
AF:
0.000620
ExAC
AF:
0.000154
AC:
14

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:11Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:7
Uncertain significance, no assertion criteria providedprovider interpretationStanford Center for Inherited Cardiovascular Disease, Stanford UniversityApr 05, 2017- -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityNov 14, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 30, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicMar 17, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 24, 2024Identified in an individual with suspected limb-girdle muscular dystrophy; however, no second reportable FKRP variant was identified (PMID: 30564623); In silico analysis indicates that this missense variant does not alter protein structure/function; Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; This variant is associated with the following publications: (PMID: 31638414, 31862442, 30564623, 27439679) -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenDec 01, 2022FKRP: PM2, PP3 -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsOct 16, 2024Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) Polyphen and MutationTaster predict this amino acid change may be benign. -
Autosomal recessive limb-girdle muscular dystrophy type 2I;C1847759:Muscular dystrophy-dystroglycanopathy type B5;C3150413:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;C4284790:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 12, 2022- -
Autosomal recessive limb-girdle muscular dystrophy type 2I Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Jan 08, 2020- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoOct 13, 2016- -
Autosomal recessive limb-girdle muscular dystrophy type 2I;C1847759:Muscular dystrophy-dystroglycanopathy type B5;C3150413:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021FKRP NM_024301.4 exon 4 p.Ser152Arg (c.456C>G): This variant has not been reported in the literature and is present in 0.1% (72/60014) of European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/19-47259163-C-G). This variant is present in ClinVar (Variation ID:289565). This variant amino acid Arginine (Arg) is present in multiple species including the green seaturtle, painted turtle, chinese softshell turtle, and spiny softshell turtle, and it is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Walker-Warburg congenital muscular dystrophy Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
0.026
DANN
Benign
0.28
DEOGEN2
Benign
0.20
.;T;T;.
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.034
N
LIST_S2
Benign
0.52
T;.;T;T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.013
T;T;T;T
MetaSVM
Uncertain
0.65
D
MutationAssessor
Benign
0.0
.;N;N;.
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.44
.;N;N;.
REVEL
Benign
0.20
Sift
Benign
0.51
.;T;T;.
Sift4G
Benign
0.52
T;T;T;T
Polyphen
0.026
.;B;B;.
Vest4
0.038, 0.026
MutPred
0.42
Gain of methylation at S152 (P = 0.0065);Gain of methylation at S152 (P = 0.0065);Gain of methylation at S152 (P = 0.0065);.;
MVP
0.52
MPC
0.70
ClinPred
0.019
T
GERP RS
-6.4
Varity_R
0.069
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199714523; hg19: chr19-47259163; API